Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells

British Journal of Cancer

Volumn 103, Issue 7, 2010, Pages 975-986

  Strillacci, A ^a   Griffoni, C ^a   Lazzarini, G ^a,b   Valerii, M C ^a,b   Di Molfetta, S ^a   Rizzello, F ^a   Campieri, M ^b   Moyer, M P ^c   Tomasi, V ^a   Spisni, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INCELL Corporation ^*  (United States)

Author keywords

COX 2; CRC; E. coli; RNAi

Indexed keywords

CYCLOOXYGENASE 2; PROSTAGLANDIN E2; SHORT HAIRPIN RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANCER INVASION; CELL SURVIVAL; COLON; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME INHIBITION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RNA INTERFERENCE; BIOSYNTHESIS; CELL PROLIFERATION; COLON TUMOR; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; TUMOR CELL LINE; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; ESCHERICHIA COLI; HUMANS; RNA INTERFERENCE; TRANSFECTION; UP-REGULATION;

EID: 77957237991     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605859     Document Type: Article

References (53)

1. Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, Rose-John S, Neurath MF (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4: 217-220 (Pubitemid 41365319)
2. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T (2005) Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 179: 56-65 (Pubitemid 40976289)
3. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98: 10356-10361 (Pubitemid 32803024)
4. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA, Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352: 1092-1102 (Pubitemid 40365350)
5. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12: 78-85 (Pubitemid 30042685)
6. Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247 (Pubitemid 41043979)
7. Caporale A, Brescia A, Galati G, Castelli M, Saputo S, Terrenato I, Cucina A, Liverani A, Gasparrini M, Ciardi A, Scarpini M, Cosenza UM (2007) Locoregional IL-2 therapy in the treatment of colon cancer. Cell-induced lesions of a murine model. Anticancer Res 27: 985-989 (Pubitemid 46587010)
8. Castagliuolo I, Beggiao E, Brun P, Barzon L, Goussard S, Manganelli R, Grillot-Courvalin C, Palù G (2005) Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther 12: 1070-1078 (Pubitemid 40946149)
9. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axinbeta- catenin signaling axis. Science 310: 1504-1510
10. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179 (Pubitemid 41806407)
11. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, Hla T (1994) Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest 93: 1095-1101 (Pubitemid 24087162)
12. Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA, Prescott SM (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108: 1657-1665
13. DuBois RN, Radhika A, Reddy BS, Entingh AJ (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262 (Pubitemid 26113767)
14. Duque J, Fresno M, Iñiguez MA (2005) Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 280: 8686-8693 (Pubitemid 40409556)
15. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188 (Pubitemid 24294584)
16. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592 (Pubitemid 46359643)
17. Galzie Z, Fernig DG, Smith JA, Poston GJ, Kinsella AR (1997) Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor. Int J Cancer 71: 390-395 (Pubitemid 27224303)
18. Griffoni C, Spisni E, Strillacci A, Toni M, Bachschmid MM, Tomasi V (2007) Selective inhibition of prostacyclin synthase activity by rofecoxib. J Cell Mol Med 11: 327-338 (Pubitemid 46693331)
19. Grillot-Courvalin C, Goussard S, Huetz F, Ojcius DM, Courvalin P (1998) Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotechnol 16: 862-866 (Pubitemid 28405858)
20. Han SY, Lee MS, Kim HR, Baek SH, Ahn DH, Chae HS, Erickson RH, Sleisenger MH, Kim YS (2000) Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells. Int J Oncol 17: 487-494
21. Higuchi T, Iwama T, Yoshinaga K, Toyooka M, Taketo MM, Sugihara K (2003) A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 9: 4756-4760 (Pubitemid 37323278)
22. Hla T, Neilson K (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89: 7384-7388
23. Hsu S, Huang F, Friedman E (1995) Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect. J Cell Physiol 165: 239-245
24. Iñiguez MA, Rodriguez A, Volpert OV, Fresno M, Redondo JM (2003) Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol Med 9: 73-78 (Pubitemid 36313868)
25. Kaidi A, Qualtrough D, Williams AC, Paraskeva C (2006) Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 66: 6683-6691 (Pubitemid 44085625)
26. Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M (2005) Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology 68: 138-145 (Pubitemid 41158969)
27. Koshiji M, Adachi Y, Sogo S, Taketani S, Oyaizu N, Than S, Inaba M, Phawa S, Hioki K, Ikehara S (1998) Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol 111: 211-218 (Pubitemid 28062800)
28. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32: 107-108 (Pubitemid 34977204)
29. Liu W, Reinmuth N, Stoeltzing O, Parikh AA, Tellez C, Williams S, Jung YD, Fan F, Takeda A, Akagi M, Bar-Eli M, Gallick GE, Ellis LM (2003) Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res 63: 3632-3636 (Pubitemid 36793046)
30. Matsuo Y, Sawai H, Ma J, Xu D, Ochi N, Yasuda A, Takahashi H, Funahashi H, Takeyama H (2009) IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells potential for liver metastasis. J Surg Oncol 99: 361-367
31. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790 (Pubitemid 27136715)
32. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR (1996) NCM460, anormal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32: 315-317
33. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809 (Pubitemid 26404280)
34. Phillips RK, Wallace MH, Lynch PM, Hawk E, Gordon GB, Saunders BP, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Su LK, Sherman J, Kelloff G, Levin B, Steinbach G, FAP Study Group (2002) A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50: 857-860 (Pubitemid 34539050)
35. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118: 560-570 (Pubitemid 351206546)
36. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348: 883-890 (Pubitemid 36297996)
37. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789
38. Sansone P, Piazzi G, Paterini P, Strillacci A, Ceccarelli C, Minni F, Biasco G, Chieco P, Bonafè M (2009) Cyclooxygenase-2/Carbonic anhydrase-IX upregulation promotes invasive potential and hypoxia survival in colorectal cancer cells. J Cell Mol Med 13: 3876-3887
39. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BRG (2003) Activation of the interferon system by short-interfering RNAs. Nature Cell Biol 5: 834-839 (Pubitemid 37087172)
40. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M, Adenoma Prevention with Celecoxib (APC) Study Investigators (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352: 1071-1080 (Pubitemid 40365348)
41. Spisni E, Tomasi V (1997) Involvement of prostanoid in angiogenesis. In Tumour Angiogenesis. Bicknell R, Lewis CE, Ferrara N (Eds). Oxford University Press: Oxford, UK. pp 291- 300
42. Strillacci A, Griffoni C, Sansone P, Paterini P, Piazzi G, Lazzarini G, Spisni E, Pantaleo MA, Biasco G, Tomasi V (2009) MiR-101 is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 315: 1439-1447
43. Strillacci A, Griffoni C, Spisni E, Manara MC, Tomasi V (2006) RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumor cells. Br J Cancer 94: 1300-1310
44. Strillacci A, Griffoni C, Valerii MC, Lazzarini G, Tomasi V, Spisni E (2010) RNAi-based strategies for cyclooxygenase-2 (COX-2) inhibition in cancer. RNAi-based strategies for cyclooxygenase-2 (COX-2) inhibition in cancer. J Biomed Biotechnol 2010: 828045
45. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968
46. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266 (Pubitemid 34196319)
47. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501
48. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111: 1134-1140 (Pubitemid 26327618)
49. Wu KK, Liou JY, Cieslik K (2005) Transcriptional control of COX-2 via C/ EBPbeta. Arterioscler Thromb Vasc Biol 25: 679-685 (Pubitemid 40463853)
50. Xiang S, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 24: 697-702 (Pubitemid 43882121)
51. Yamamoto K, Arakawa T, Ueda N, Yamamoto S (1995) Transcriptional roles of nuclear factor kappa B and nuclear factorinterleukin- 6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-31320 (Pubitemid 26012222)
52. Yamauchi T, Watanabe M, Kubota T, Hasegawa H, Ishii Y, Endo T, Kabeshima Y, Yorozuya K, Yamamoto K, Mukai M, Kitajima M (2002) Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum 45: 98-103 (Pubitemid 34072758)
53. Zhang M, Yao Z, Dubois S, Ju W, Müller JR, Waldmann TA (2009) Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci USA 106: 7513-7518